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Abstract
Objective To determine whether supplementation of
infant formula milk with long chain polyunsaturated
fatty acids (LCPUFAs) influences blood pressure in
later childhood.
Design Follow up of a multicentre, randomised
controlled trial.
Setting Four study centres in Europe.
Participants 147 formula fed children, with a
reference group of 88 breastfed children.
Intervention In the original trial newborn infants
were randomised to be fed with a formula
supplemented with LCPUFAs (n=111) or a formula
without LCPUFAs but otherwise nutritionally similar
(n=126). In the present follow up study the blood
pressure of the children at age 6 years was measured.
Main outcome measures Systolic, diastolic, and mean
blood pressure.
Results 71 children in the LCPUFA supplementation
group (64% of the original group) and 76 children in
the non-supplementation group (60%) were enrolled
into the follow up study. The LCPUFA group had
significantly lower mean blood pressure (mean
difference − 3.0 mm Hg (95% confidence interval
− 5.4 mm Hg to − 0.5 mm Hg)) and diastolic blood
pressure (mean difference − 3.6 mm Hg ( − 6.5 mm
Hg to − 0.6 mm Hg)) than the non-supplementation
group. The diastolic pressure of the breastfed children
(n=88 (63%)) was significantly lower than that of the
non-supplemented formula group but did not differ
from the LCPUFA formula group.
Conclusions Dietary supplementation with LCPUFAs
during infancy is associated with lower blood pressure
in later childhood. Blood pressure tends to track from
childhood into adult life, so early exposure to dietary
LCPUFAs may reduce cardiovascular risk in
adulthood.
Introduction
Recent reports have linked breast feeding in infancy to
lower blood pressure during childhood. Two longitudi-
nal observational studies of term infants showed that
children who were breast fed for at least three months
had lower systolic and diastolic blood pressures in later
childhood and adolescence than children who were
formula fed. This difference remained after adjustment
for known confounding variables.1 2 A study involving
preterm infants who had been randomised to be fed
with banked breast milk had lower systolic and diasto-
lic blood pressures at the age of 15 years than children
who were fed term or preterm formula.3
The mechanisms underlying the relation between
breast feeding in infancy and blood pressure during
childhood are unclear. The study involving preterm
infants found no difference in blood pressure of
infants who were fed a term formula and infants who
were fed a preterm formula that contained additional
protein, energy, and minerals, including sodium.3
Breast milk contains a wide range of substances—
trophic substances, hormones, and specific nutrients—
that are not included in formulas and that may
influence blood pressure.
Considerable interest has been shown recently in
the role of long chain polyunsaturated fatty acids
(LCPUFAs), as these fatty acids are in breast milk but
are not routinely available in formula milks.4 During
the first weeks of life preterm infants and some term
infants may not be able to synthesise enough
LCPUFAs to meet demand, and therefore infants fed
with formula without supplementation may be
relatively deficient in LCPUFAs, compared with breast-
fed infants. As these fatty acids are preferentially incor-
porated into neural cell membranes, studies have
predominantly focused on the influence of fatty acids
on visual and cognitive development.5 6 However, it is
also known that LCPUFAs are incorporated into other
cell membranes, including vascular endothelium.7 8
Several studies have reported lower blood pressure in
adults whose diet was supplemented with omega 3
fatty acids, but no published studies have looked at the
effect of LCPUFA supplementation on blood pressure
in children.9 10
In an earlier tolerance study of LCPUFA supple-
mentation and its effect on cognitive development we
randomly assigned newborn infants to be fed with a
formula containing LCPUFAs or to a formula without
LCPUFAs but otherwise nutritionally similar.6 11 We
therefore had the opportunity to further investigate
the randomised groups to determine the relation of
LCPUFA supplementation in infancy to blood
pressure in later childhood.
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Methods
In 1992 six European centres took part in a
multicentre, randomised controlled trial of a new
infant formula that was supplemented with docosa-
hexaenoic acid and arachidonic acid.6 Four of the cen-
tres that contributed to this original tolerance and
safety study agreed to take part in the present follow up
study. Each centre (Dundee and Birmingham in the
United Kingdom, Leuven in Belgium, and Milan in
Italy) had a cohort of 6 year old children who as infants
had been randomised to be fed one of the trial formu-
las and a reference group of breastfed children. Each
centre obtained consent from the parent or guardian
of the child. The figure shows the numbers of children
who participated in the original trial and the follow up
study.
The children had all been born between 37 and 42
weeks’ gestation and weighed between 2500 g and
4000 g at birth. A computer generated randomisation
table was used to assign the infants immediately after
birth to a formula supplemented with LCPUFAs or a
formula without supplementation. Permutated blocks
of six were used, so that after every sixth infant the two
groups were numerically balanced. Randomisation was
stratified to ensure sex matching. Table 1 shows the
composition of the formulas. The LCPUFA source was
egg yolk, with approximately 70% of LCPUFAs being
esters of phospholipids.
Each of the children was fed the trial formula dur-
ing the first four months of life. Each month the
children’s weight, length, head circumference, sub-
scapular skinfold thickness, and mid-arm circumfer-
ence were measured. Other factors relating to safety
and tolerance were also recorded.
In the present follow up study the children and
their families were invited to attend a clinic or
laboratory in the relevant study centre. During the
visits, which took place between April 1998 and March
2000, a demographic and clinical questionnaire was
completed and the child’s blood pressure measured.
Psychological assessments were also done (data not
included).
Blood pressure was measured while the child was
sitting on a chair with the right arm held in the
horizontal position. In all centres staff used an
automated blood pressure monitor (OMRON 711
Automatic IS, Omron Healthcare, Hamburg, Ger-
many) with a child cuff (type 40S, 15-22 cm). Systolic,
diastolic, and mean blood pressures were recorded as
the average of three readings. Throughout both studies
research assistants and parents or guardians were blind
to the formula each child had received.
Previous studies have shown the standard deviation
of childhood blood pressure measurements to be
8 mm Hg, and so we calculated that a sample size of 63
children in each group was needed to detect a
difference of 4 mm Hg with a power of 80% at the 0.05
level of significance. We used Student’s t test to
compare normally distributed variables.
Results
Nearly two thirds (235/376) of the participants in the
original tolerance and safety study were recruited to
the present study (table 2). The figure shows the
reasons for non-enrolment in the present study. Com-
pared with the children from the randomised groups
who took part in the follow up study, the children who
did not take part had a lower birth weight (mean (SD)
3108 g (411 g) v 3292 g (397 g); P=0.001), length
(49.8 cm (2.0 cm) v 50.5 cm (2.6 cm); P=0.04), and
mid-arm circumference (10.1 cm (0.9 cm) v 10.5 cm
(1.0 cm); P=0.007).
The mean age of the children at the time of blood
pressure assessment was 70.1 months (SD 3.5 months).
There were no demographic or anthropometrical
differences between the two randomised groups at the
time of the follow up (table 3). As expected, there were
social differences between the formula fed children
and the reference group of breastfed children: children
who were breast fed had more siblings, fewer smokers
in the family, older parents, and fathers who were more
educated (table 4).
Six children declined to have their blood pressure
measured. In 10 children technical difficulties resulted
in unreliable data being obtained, and attempts to
repeat the measurements were unsuccessful. The final
analysis was on 219 children (65 in the LCPUFA
group, 71 in the non-LCPUFA group, and 83 breastfed
children).
Diastolic blood pressure was significantly lower in
the LCPUFA group than in the non-LCPUFA group
Infants randomised to be
fed formula milk (n=237)
Infants received control
formula without
supplementation (n=126)
Not enrolled (n=50):
 Not traced (n=22)
 Relocated (n=10)
 Medical reason (n=1)
 Consent refused (n=9)
 Other reasons (n=8)
Infants received formula
supplemented with long
chain polyunsaturated
fatty acids (n=111)
Children enrolled for follow
up at 6 years (n=76)
Blood pressure
measured (n=71)
Blood pressure not
measured in 5 children:
 Declined (n=2)
 Technical difficulties
   (n=3)
Not enrolled (n=40):
 Not traced (n=23)
 Relocated (n=7)
 Medical reason (n=1)
 Consent refused (n=7)
 Other reasons (n=2)
Original study
Follow up study
at age 6 years
Children enrolled for follow
up at 6 years (n=71)
Blood pressure
measured (n=65)
Blood pressure not
measured in 6 children:
 Declined (n=3)
 Technical difficulties
   (n=3)
Reference group of
breastfed infants (n=139)
Not enrolled (n=51):
 Not traced (n=24)
 Relocated (n=11)
 Medical reason (n=1)
 Consent refused (n=13)
 Other reasons (n=2)
Children enrolled for follow
up at 6 years (n=88)
Blood pressure
measured (n=83)
Blood pressure not
measured in 5 children:
 Declined (n=2)
 Technical difficulties
   (n=3)
Flow of participants through the original trial of infant formula feed and the follow up study
at age 6 years
Table 1 Fatty acid composition (g per 100 g of fat) of the two infant formulas
Fatty acid
Formula with LCPUFA
supplementation
Formula without
supplementation
Linoleic acid 11.5 to 12.8 11.4
 linolenic acid 0.6 to 0.65 0.7
Arachidonic acid 0.3 to 0.4 <0.1
Docosahexaenoic acid 0.15 to 0.25 0
LCPUFA=long chain polyunsaturated fatty acid.
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(table 5). Systolic blood pressure was also lower, but not
significantly. However, mean blood pressure was signifi-
cantly lower in the LCPUFA group than in the
non-LCPUFA group. The blood pressure of the breast-
fed children was 92.5 mm Hg systolic (SD 9.7 mm Hg)
and 57.5 mm Hg diastolic (SD 8.5 mm Hg). The diasto-
lic pressure of breastfed children was significantly lower
than that of the non-LCPUFA group (mean difference
− 3.4 mm Hg (95% confidence interval − 6.8 mm Hg to
− 0.01 mm Hg; P=0.02)) but did not differ from that of
the LCPUFA group.
Discussion
Blood pressure at age 6 years was lower in children
who as infants had been fed with a formula
supplemented with LCPUFAs than in children who
were fed a formula without LCPUFAs. Blood pressure
in the reference group of breastfed children was simi-
lar to that in the supplemented formula group, but a
direct comparison of the two groups is not possible
because of confounding variables (including milk com-
position, age and education of fathers, and family
history of smoking).
Table 2 Proportions (percentage) of children in the original trial of types of infant formula who took part in the present follow up
study
Centre
Formula with LCPUFA
supplementation
Formula without
supplementation Breastfed children* Total
Birmingham 11/14 (79) 6/15 (40) 16/26 (62) 33/55 (60)
Dundee 27/40 (68) 32/50 (64) 30/43 (70) 89/133 (67)
Leuven 19/30 (63) 20/30 (67) 24/38 (70) 63/98 (64)
Milan 14/27 (52) 18/31 (58) 18/32 (56) 50/90 (56)
Total 71/111 (64) 76/126 (60) 88/139 (63) 235/376 (63)
LCPUFA=long chain polyunsaturated fatty acid.
*Reference group.
Table 3 Characteristics of children in the original trial of types of infant formula who were enrolled into the follow up study. Figures
are means (SD) except where otherwise indicated
Characteristics Formula with LCPUFA supplementation (n=71) Formula without supplementation (n=76)
Demographic characteristics
Age of mother (years) at follow up 34.2 (5.8) 34.6 (5.4)
Age of mother (years) at completion of education 18.4 (3.4) 18.0 (2.8)
Age of father (years) at follow up 36.1 (5.8) 36.0 (4.7)
Age of father (years) at completion of education 17.7 (3.1) 17.9 (2.6)
No of mothers married or with partner/No of single mothers* 61/8 69/6
No of children in home 2.1 (1.0) 2.0 (0.9)
No of smokers in household 0.82 0.74
Sex ratio (male/female) in group 41/30 37/39
Gestation (weeks) 39.4 (1.5) 39.5 (1.3)
Child’s age at assessment (months) 70.1 (3.8) 70.0 (3.1)
Anthropometry at birth
Weight (g) 3293 (438) 3291 (359)
Crown-heel length (cm) 50.5 (2.8) 50.5 (2.5)
Occipitofrontal circumference (cm) 34.7 (1.4) 34.8 (2.4)
Mid-upper arm circumference (cm) 10.5 (1.1) 10.4 (0.9)
Subscapular skinfold (mm) 4.7 (1.2) 4.6 (0.9)
Triceps skinfold (mm) 4.8 (1.2) 4.8 (0.9)
LCPUFA=long chain polyunsaturated fatty acid.
*Marital status of three mothers not known.
Table 4 Characteristics of children in the original trial of types of infant formula who were enrolled into the follow up study,
compared with reference group of breastfed children. Figures are means (SD) except where otherwise indicated
Characteristics Formula fed children (n=147) Breast fed children (n=88) P value
Age of mother (years) at follow up 34.4 (5.6) 35.9 (4.1) 0.031
Age of mother (years) at completion of
education
18.2 (3.1) 18.9 (3.6) 0.111
Age of father (years) at follow up 36.0 (5.3) 39.2 (5.1) 0.0001
Age of father (years) at completion of education 17.8 (2.8) 19.5 (4.8) 0.003
No of mothers married or with partner/No of
single mothers*
130/14 78/5 0.239
No of children in home 2.1 (1.0) 2.5 (1.2) 0.01
No of smokers in household 0.78 (0.75) 0.35 (0.60) 0.0001
Table 5 Blood pressure (mm Hg) at age 6 years in children who as infants had been
randomised to be fed with formula supplemented with long chain polyunsaturated fatty
acids or with formula without supplementation
Blood pressure
Supplemented
formula (n=65)
Formula without
supplementation
(n=71)
Mean difference
(95% CI) P value
Mean 74.8 77.8 −3.0 (−5.4 to −0.5) 0.02
Diastolic 57.3 60.9 −3.6 (−6.5 to −0.6) 0.018
Systolic 92.4 94.7 −2.3 (−5.3 to 0.7) 0.132
Papers
page 3 of 5BMJ VOLUME 326 3 MAY 2003 bmj.com
Strengths and limitations of the study
The multicentre cohort consisted of children who were
born healthy at full term and who were randomised at
birth to one of the study formulas. The infants
remained on the assigned formula for four months, but
data on subsequent diet were not collected. Nearly two
thirds of the original group took part in the present
study of blood pressure. Social characteristics of the
children who did not take part in the follow up study
did not differ from those of the participants, but mean
weight, length, and mid-arm circumference at birth
were all lower in the children who did not participate.
The impact of these anthropometrical differences on
our results is uncertain. However, it has been shown
that the amount of stored LCPUFAs at birth is directly
related to birth weight12; it could therefore be
postulated that the effect of LCPUFA supplementation
in lowering blood pressure might have been more
marked among the children who did not take part in
the present study.
Mechanisms of action
The mechanisms underlying the relation of LCPUFAs
to blood pressure remain uncertain. Several studies of
adults with hypertension have shown that an increased
dietary intake of omega 3 fatty acids is associated with
lower blood pressure.9 A double blind, placebo
controlled trial showed that docosahexaenoic acid but
not eicosapentaenoic acid lowered ambulatory blood
pressure in overweight men.10 The authors of this trial
reported in another study of the same cohort that
docosahexaenoic acid enhanced dilatory responses to
sodium nitroprusside and attenuated constrictor
responses to noradrenaline.13 These data are sup-
ported by animal studies that have shown lower blood
pressure in rats that were fed a diet enriched with
docosahexaenoic acid, compared with rats on a control
diet.14 15 Data relating omega 6 fatty acids to blood
pressure are more limited. One study of weanling male
rats showed that systolic blood pressure was inversely
related to intake of linoleic acid.16 In our study the con-
centration of linoleic acid was similar in the two
formulas, and it is uncertain whether the additional
arachidonic acid in the trial formula influenced this
metabolic pathway.
Implications
Our results support an association between early
nutritional intervention and health benefits in later life.
Whether the influence of LCPUFAs on blood pressure
would have been stronger with a longer period of sup-
plementation is uncertain. A recent animal study noted
higher blood pressure in adult rats that were deficient
in omega 3 fatty acids in the perinatal period, and this
increase in blood pressure was not prevented by later
repletion with fatty acids.17
Blood pressure is known to track from childhood
into adult life, and deviations from normal blood pres-
sure during childhood are amplified in later life.18 Our
findings are therefore relevant to public health
strategies aimed at improving the long term health of
the population. It has previously been reported that
lowering a population’s diastolic blood pressure by
even a few millimetres can significantly reduce
hypertension, coronary heart disease, and stroke.19 20
These benefits can be achieved by simple dietary
measures early in life.
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